Search Results for:

Predictions can bring excitement, make you more aware, or produce a sense of call to action. Attendees at Outsourcing Clinical Trials West Coast 2022 in Burlingame, CA had the opportunity to experience one or more of those feelings while hearing from Anju Software’s EVP of Operations, Mike Keens, as he gave an update on his 2021 […]

Most people and organizations are wary of change. New processes and opportunities create risks that could outweigh the benefits of deviating from the norm. But then a global pandemic grinds industry to a halt and requires innovations at speeds that were previously unheard of. This is what has occurred with direct-to-patient (DTP) clinical trials.   Even as […]

The use of decentralized clinical trials (DCTs) has become increasingly common, especially over the past 18 months. The COVID-19 pandemic made it dangerous to leave the house, particularly for patients with weakened immune systems. Since the start of the pandemic, the meaning of decentralized studies has evolved and new technologies have been introduced to accommodate trial leaders. […]

The use of decentralized clinical trials (DCTs) has increased significantly over the past year. Researchers were forced into this option because of hospital limits and local lockdowns created by the COVID-19 pandemic. However, as vaccine rates have increased, the use of decentralized trials have remained high. This trial method is the future. Here’s how researchers […]

Remote environments often create logistical challenges for trial developers. How can researchers ensure the data collected is accurate? How can they know if patients followed directions in administration and reporting? Alongside these questions, there are security concerns. Clinical research organizations (CROs) and sponsors need to protect the privacy of their patients and prevent their organizations […]

Decentralized clinical trials allow researchers to connect with patients across the country and the world. In the case of treatments for rare diseases, decentralized trials can increase participation and create safer, more comfortable experiences for patients.   However, there is still a burden on clinical research organizations (CROs) and sponsors to choose ideal trial sites. […]

Decentralized clinical trials (DCTs) are changing how researchers evaluate treatments. However, these trials vary from organization to organization. Different levels of technology contribute to how decentralized a trial is, with more adaptive systems offering better flexibility.   The success of a trial isn’t based on its technology use, but the right tools can improve data […]

Artificial intelligence and machine learning are revolutionizing early-stage clinical trials. Technology has the power to speed up these trials — meaning they move to late-stage testing and to the general market faster — while also making them safer.   One way AI tools protect patients is with synthetic data, using either simulated data or obscured […]

Technology plays an ever-growing role in clinical research. This includes everything from the adoption of electronic trial master files to the proliferation of virtual clinical trials. It’s the latter trend that holds special promise in the realm of clinical research. As more and more trials are conducted remotely, new opportunities arise. New patients can be […]

In March 2019, the FDA published a flurry of guidance documents regarding clinical trials. There was guidance for sponsors, and guidance for industry on Severely Debilitating or Life-Threatening Hematologic Disorders (SDLTHDs).   With these publications came a statement from then-FDA Commissioner Scott Gottlieb, who encouraged the industry to further embrace the innovations that facilitate decentralized clinical […]